Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:OSI_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2005
|
| gptkbp:focusesOn |
ophthalmology
|
| gptkbp:foundedIn |
2000
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eyetech Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableEmployee |
David R. Guyer
|
| gptkbp:notableProduct |
gptkb:Macugen
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
treatments for eye diseases
|
| gptkbp:stockSymbol |
EYET
|
| gptkbp:bfsParent |
gptkb:Glenn_P._Sblendorio
gptkb:pegaptanib |
| gptkbp:bfsLayer |
7
|